BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33828598)

  • 1. Alantolactone inhibits stem-like cell phenotype, chemoresistance and metastasis in PC3 cells through STAT3 signaling pathway.
    Babaei G; Khadem Ansari MH; Aziz SG; Bazl MR
    Res Pharm Sci; 2020 Dec; 15(6):551-562. PubMed ID: 33828598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway.
    Zhang C; Ma K; Li WY
    J Cancer; 2019; 10(26):6511-6525. PubMed ID: 31777581
    [No Abstract]   [Full Text] [Related]  

  • 3. The natural flavonoid apigenin sensitizes human CD44
    Erdogan S; Turkekul K; Serttas R; Erdogan Z
    Biomed Pharmacother; 2017 Apr; 88():210-217. PubMed ID: 28107698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apatinib ameliorates doxorubicin-induced migration and cancer stemness of osteosarcoma cells by inhibiting Sox2 via STAT3 signalling.
    Tian ZC; Wang JQ; Ge H
    J Orthop Translat; 2020 May; 22():132-141. PubMed ID: 32440509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of ovatodiolide, a macrocyclic diterpenoid, as a potential inhibitor of oral cancer stem-like cells properties via the inhibition of the JAK2/STAT3/JARID1B signal circuit.
    Lin CS; Bamodu OA; Kuo KT; Huang CM; Liu SC; Wang CH; Tzeng YM; Chao TY; Yeh CT
    Phytomedicine; 2018 Jul; 46():93-103. PubMed ID: 30097127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway.
    Zhang C; Ma K; Li WY
    Drug Des Devel Ther; 2019; 13():4075-4090. PubMed ID: 31824138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
    Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties.
    Liu YQ; Wang SK; Xu QQ; Yuan HQ; Guo YX; Wang Q; Kong F; Lin ZM; Sun DQ; Wang RM; Lou HX
    Acta Pharmacol Sin; 2019 May; 40(5):689-698. PubMed ID: 30171201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial Lipopolysaccharide Augmented Malignant Transformation and Promoted the Stemness in Prostate Cancer Epithelial Cells.
    Tang S; Lian X; Cheng H; Guo J; Ni D; Huang C; Gu X; Meng H; Jiang J; Li X
    J Inflamm Res; 2021; 14():5849-5862. PubMed ID: 34785925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K/Akt/NF-κB signaling.
    Erdogan S; Doganlar O; Doganlar ZB; Serttas R; Turkekul K; Dibirdik I; Bilir A
    Life Sci; 2016 Oct; 162():77-86. PubMed ID: 27569589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genistein inhibits the stemness properties of prostate cancer cells through targeting Hedgehog-Gli1 pathway.
    Zhang L; Li L; Jiao M; Wu D; Wu K; Li X; Zhu G; Yang L; Wang X; Hsieh JT; He D
    Cancer Lett; 2012 Oct; 323(1):48-57. PubMed ID: 22484470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells.
    Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P
    World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis-promoting and migration-suppressing effect of alantolactone on gastric cancer cell lines BGC-823 and SGC-7901 via regulating p38MAPK and NF-κB pathways.
    He Y; Cao X; Kong Y; Wang S; Xia Y; Bi R; Liu J
    Hum Exp Toxicol; 2019 Oct; 38(10):1132-1144. PubMed ID: 31203647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nimbolide inhibits 2D and 3D prostate cancer cells migration, affects microtubules and angiogenesis and suppresses B-RAF/p.ERK-mediated in vivo tumor growth.
    Mahmoud N; Dawood M; Huang Q; Ng JPL; Ren F; Wong VKW; Efferth T
    Phytomedicine; 2022 Jan; 94():153826. PubMed ID: 34775358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
    Liao CP; Lin TP; Li PC; Geary LA; Chen K; Vaikari VP; Wu JB; Lin CH; Gross ME; Shih JC
    Oncogene; 2018 Sep; 37(38):5175-5190. PubMed ID: 29844571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neferine inhibits proliferation and migration of human prostate cancer stem cells through p38 MAPK/JNK activation.
    Erdogan S; Turkekul K
    J Food Biochem; 2020 Jul; 44(7):e13253. PubMed ID: 32394497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway.
    Erdogan S; Turkekul K; Dibirdik I; Doganlar O; Doganlar ZB; Bilir A; Oktem G
    Biomed Pharmacother; 2018 Nov; 107():793-805. PubMed ID: 30142541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells.
    Chun J; Li RJ; Cheng MS; Kim YS
    Cancer Lett; 2015 Feb; 357(1):393-403. PubMed ID: 25434800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.